Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.91 and traded as low as $0.74. Pharma-Bio Serv shares last traded at $0.74, with a volume of 5,317 shares traded.
Pharma-Bio Serv Stock Up 5.0 %
The business’s 50-day moving average price is $0.85 and its 200-day moving average price is $0.91. The firm has a market capitalization of $16.88 million, a PE ratio of 24.51 and a beta of 0.51.
Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) last posted its quarterly earnings results on Monday, March 18th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.03). The company had revenue of $2.38 million during the quarter, compared to analysts’ expectations of $5.00 million. Pharma-Bio Serv had a return on equity of 3.95% and a net margin of 4.05%. On average, analysts anticipate that Pharma-Bio Serv, Inc. will post 0.08 EPS for the current fiscal year.
About Pharma-Bio Serv
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
Featured Articles
- Five stocks we like better than Pharma-Bio Serv
- Learn Technical Analysis Skills to Master the Stock Market
- Hasbro’s Management Made All the Right Calls This Quarter
- What is the S&P/TSX Index?
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- 3 Small Caps With Big Return Potential
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.